Parkinson'S Disease Treatment Market Grow at a CAGR of 7.7% with Top Market Players: GlaxoSmithKline, Abbvie, Acadia, Boehringer Ingelheim, Daiichi Sankyo, Impax Laboratories

Industry Highlights

According to Market Prognosis, the Global Parkinson'S Disease Treatment market is accounted for $4.08 billion in 2017 and is expected to reach $7.93 billion by 2026 growing at a CAGR of 7.7%. Growing geriatric population coupled with neurological disorders, increasing investments in research & development activities, and raising healthcare awareness are some of the factors propelling the market growth during the forecast period. However, availability of other treatments is hindering the market growth.

Get Sample Report @ https://marketprognosis.com/sample-request/15245

Market Top Player’s

Some of the key players in Parkinson’s disease Treatment market include GlaxoSmithKline Plc., Abbvie, Acadia, Boehringer Ingelheim, Daiichi Sankyo, Impax Laboratories, Inc., Lundbeck, Merck, Novartis, Salix Pharmaceuticals, Sun Pharma, Teva Pharmaceutical Industries Ltd., UCB, Valeant Pharmaceuticals, and Wockhardt Limited.

What our report offers:

- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Ask For Discount @ https://marketprognosis.com/discount-request/15245

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Market Segments

By therapeutic class, Carbidopa/Levodopa segment is prognosticated to witness strong growth rate over the forecast period due to its potentiality and large acceptance for the parkinson’s disease treatment. Besides, online pharmacies are projected to grow at a higher growth rate during the forecast period.

By region, Asia Pacific is expected to witness highest growth rate due to growing medical tourism trend and raising medical infrastructure. Europe is dominating the global market with highest market revenue during the forecast period. This dominance is driven by increasing geriatric population and raising expenses on healthcare.

Therapeutic Class:
• Monoamine oxidase B inhibitors (MAO-B inhibitors)
• Dopamine precursors
• Dopamine agonists (non-ergoline)
• Catechol-O-methyl transferase (COMT) inhibitors
• Carbidopa/Levodopa
• Other Therapeutic Classes
Medical Devices:
• Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices
• Deep Brain Stimulation (DBS) Devices
Patient Care Setting:
• Hospitals
• Clinics
Distribution Channel:
• Retail pharmacies
• Online pharmacies
• Hospital pharmacies
• Drug stores

Enquiry Before Buying @ https://marketprognosis.com/enquiry/15245

About Us
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact
ProgMark Pvt Ltd,
Thane - 421501
India. Contact- +1 973 241 5193
Email- sales@marketprognosis.com

This release was published on openPR.